Key Details
Price
$19.08Last Dividend
$0.16Annual Revenue
$3.96 BAnnual EPS
-$0.62Annual ROE
-3.72%Beta
0.60Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Feb 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 27, 2024Next split:
N/ARecent split:
July 18, 2006Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120930&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120918&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120821&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK , Jan. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who purchased shares of XRAY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120769&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120747&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120670&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Dentsply securities between May 6, 2021, and November 06, 2024, both dates inclusive (the "Class Period").
LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 1, 2022 and November 6, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before January 27, 2025.
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQ: XRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 27, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered DENTS.
FAQ
- What is the primary business of DENTSPLY SIRONA?
- What is the ticker symbol for DENTSPLY SIRONA?
- Does DENTSPLY SIRONA pay dividends?
- What sector is DENTSPLY SIRONA in?
- What industry is DENTSPLY SIRONA in?
- What country is DENTSPLY SIRONA based in?
- When did DENTSPLY SIRONA go public?
- Is DENTSPLY SIRONA in the S&P 500?
- Is DENTSPLY SIRONA in the NASDAQ 100?
- Is DENTSPLY SIRONA in the Dow Jones?
- When was DENTSPLY SIRONA's last earnings report?
- When does DENTSPLY SIRONA report earnings?
- Should I buy DENTSPLY SIRONA stock now?